These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2382381)

  • 1. Estimation of the potential demand for a bovine babesiosis and anaplasmosis vaccine in Argentina.
    Späth EJ; Mangold AJ; Guglielmone AA
    Vet Parasitol; 1990 May; 36(1-2):131-40. PubMed ID: 2382381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of cattle producers in the Boophilus microplus endemic area of Queensland to determine attitudes to the control of and vaccination against tick fever.
    Bock RE; Blight GW; Kingston TG; de Vos AJ
    Aust Vet J; 1995 Mar; 72(3):88-92. PubMed ID: 7611988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging perspectives in the research of bovine babesiosis and anaplasmosis.
    Suarez CE; Noh S
    Vet Parasitol; 2011 Aug; 180(1-2):109-25. PubMed ID: 21684084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bovine leucosis virus contamination of a vaccine produced in vivo against bovine babesiosis and anaplasmosis.
    Rogers RJ; Dimmock CK; de Vos AJ; Rodwell BJ
    Aust Vet J; 1988 Sep; 65(9):285-7. PubMed ID: 2847702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated trivalent vaccine against babesiosis and anaplasmosis in Colombia.
    Benavides E; Vizcaino O; Britto CM; Romero A; Rubio A
    Ann N Y Acad Sci; 2000; 916():613-6. PubMed ID: 11193685
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunisation of smallholder dairy cattle against anaplasmosis and babesiosis in Malawi.
    Tjornehoj K; Lawrence JA; Kafuwa PT; Whiteland AP; Chimera BA
    Trop Anim Health Prod; 1997 May; 29(2):77-82. PubMed ID: 9203307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological evidence of exposure to tick fever organisms in young cattle on Queensland dairy farms.
    Sserugga JN; Jonsson NN; Bock RE; More SJ
    Aust Vet J; 2003 Mar; 81(3):147-52. PubMed ID: 15080428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian frozen vaccines for the control of babesiosis and anaplasmosis in cattle--a review.
    Dalgliesh RJ; Jorgensen WK; de Vos AJ
    Trop Anim Health Prod; 1990 Feb; 22(1):44-52. PubMed ID: 2181745
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization of cattle with an inactivated polyvalent vaccine against anaplasmosis and babesiosis.
    Montenegro-James S; Toro M; Leon E; Guillen AT; Lopez R; Lopez W
    Ann N Y Acad Sci; 1992 Jun; 653():112-21. PubMed ID: 1626861
    [No Abstract]   [Full Text] [Related]  

  • 10. Collection and sterilization of large volumes of bovine serum and its use in vaccines against bovine babesiosis and anaplasmosis.
    Rodwell BJ; Timms P; Parker RJ
    Aust J Exp Biol Med Sci; 1980 Apr; 58(2):143-7. PubMed ID: 7436873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods currently used for the control of anaplasmosis and babesiosis: their validity and proposals for future control strategies.
    Lawrence JA; de Vos AJ
    Parassitologia; 1990 Apr; 32(1):63-71. PubMed ID: 2284136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tick-borne diseases of cattle in Paraguay. II. Immunisation against anaplasmosis and babesiosis.
    Payne RC; Osorio O; Ybañez A
    Trop Anim Health Prod; 1990 May; 22(2):101-8. PubMed ID: 2196724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the history of research and control of Rhipicephalus (Boophilus) microplus, babesiosis and anaplasmosis in Uruguay.
    Miraballes C; Riet-Correa F
    Exp Appl Acarol; 2018 Aug; 75(4):383-398. PubMed ID: 30083875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol.
    Mangold AJ; Aguirre DH; Guglielmone AA
    Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for vaccine development against anaplasmosis and babesiosis.
    Palmer GH; McElwain TF
    Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Natural Anaplasma marginale infection in 2 cattle herds with different levels of Boophilus microplus tick infestation].
    de Rios LG; Aguirre DH; Gaido AB
    Rev Elev Med Vet Pays Trop; 1990; 43(4):447-52. PubMed ID: 2132783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine babesiosis and anaplasmosis follow-up on cattle relocated in an endemic area for hemoparasitic diseases.
    Figueroa JV; Alvarez JA; Ramos JA; Rojas EE; Santiago C; Mosqueda JJ; Vega CA; Buening GM
    Ann N Y Acad Sci; 1998 Jun; 849():1-10. PubMed ID: 9668444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhipicephalus microplus, babesiosis and anaplasmosis in Uruguay: current situation and control or elimination programs on farms.
    Miraballes C; Aráoz V; Riet-Correa F
    Exp Appl Acarol; 2019 Aug; 78(4):579-593. PubMed ID: 31352648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a frozen trivalent attenuated vaccine against Babesiosis and anaplasmosis in Brazil.
    Vidotto O; Barbosa CS; Andrade GM; Machado RZ; da Rocha MA; Silva SS
    Ann N Y Acad Sci; 1998 Jun; 849():420-3. PubMed ID: 9668502
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidemiology of babesiosis and anaplasmosis in South and Central America.
    Guglielmone AA
    Vet Parasitol; 1995 Mar; 57(1-3):109-19. PubMed ID: 7597777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.